Background: Nuclear factor-kappa B (NF-B) family comprises 5 members (p50, p52, relA/p65, c-rel and relB) which are induced in response to a wide variety of stimuli including hypoxia. Continuous activation of NF-B is an important factor in the onset and progression of breast carcinoma. Hypoxia also induces carbonic anhydrase 9 (CAIX) that regulates pH and is linked to poor prognosis in breast cancer. Research motivation: The current study aims to investigate the relation between hypoxic markers, p65, p50, CAIX and tumor stage in IDC (invasive ductal carcinoma) subtypes. Research design/methodology: The study included 31 IDC patients. Breast tissues collected during surgery and classified according to estrogen receptor alpha (ER, progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER-2) status. Normal breast tissues were also collected to serve as self controls. Nuclear protein extracted and both RelA/p65 and p50 protein assessed by ready to use enzyme-linked immunosorbent assay (ELISA) and a transcription factor assay kits; respectively. CAIX protein expression was detected by blotting techniques. Main findings: RelA/p65 concentration significantly increased in breast carcinoma (p = 0.028) irrelevant to tumor stage, size, grade, nodal status, p50, CAIX or IDC subtypes. P50 binding activity significantly increased with higher tumor grade (P = 0.042). A significant inverse correlation was observed between p50 and ER (r = -0.53, p = 0.002) and between CAIX and the number of the involved lymph nodes (r = -0.42, p = 0.020). Implications: Although no relation was observed between p65, p50, and CAIX, binding activity of p50 and CAIX concentration might be used as prognostic markers in IDC.
Introduction
Hypoxia and acidosis are hallmark features of aggressive breast cancer phenotypes (Knowles & Harris, 2001 ). Up to 1.5% of the human genome is responsive to hypoxia at the transcriptional level. The hypoxia gene expression profile varies according to the tumor type. Thus, several studies were conducted to identify the gene signatures that have prognostic significance in breast cancer (Favaro et al., 2011) . Hypoxia inducible factor-1 (HIF-1); the main sensor of hypoxia; regulates key aspects in cancer biology including pH regulation through binding to a hypoxia responsive element in the carbonic anhydrase 9 (CAIX) gene (Thiry et al., 2006) . Hypoxia also differentially regulates the activity of NF-kB (nuclear factor-kappa B) pathways and subsequent gene expression (Taylor & The transcription factor NF-B family consists of five subunits: NF-B1 (p50/p105), NF-kB2 (p52/p100), RelA (p65), RelB, and c-Rel (Ahn & Aggarwal, 2005) . The five subunits differ in the structure of the C-terminus region. NF-kB proteins have a structurally conserved Nterminal 300-amino acid region called rel homology region (RHR), which contains the dimerisation, nuclear localization, and DNA binding domains. The RHR is responsible for dimerisation, nuclear translocation (NL), DNA binding and regulation of NF-B through interaction with its inhibitor, IB (inhibitory kappa B kinases). The c-Rel, Rel B, and Rel A proteins also have a C-terminal non homologous transactivation domain (TAD) that strongly activates transcription from NF-B binding sites. P50 homodimers lack the transcription activation domain but still bind to B-consensus sites and therefore function as transcription repressors (May & Ghosh, 1997 CAIX is an enzymatic transmembrane protein which plays a role in the acidification of the extracellular environment (Nogradi, 1998 Far to our knowledge, no study investigated the relation between the hypoxic markers p65, p50, CAIX, and tumor stags in invasive ductal carcinoma (IDC) subtypes. Therefore, this study was designed to investigate this possible relationship and their impacts on patients' outcomes.
Research Design and Methodology
The study included 31 patients (sample size was based on previously published work) with IDC randomly selected from cases presented to the Cancer Management 
Protein Extraction and SDS-PAGE
Breast tissue samples (0.2 gram) were gently homogenized in 1X hypotonic buffer (20 mM Tris-HCl, pH 7.4, 10 mM NaCl, and 3 mM MgCl2) and incubated for 15 minutes on ice. Ten percent NP40 (25μL) (SigmaAldrich, Switzerland) was added and mixed by vortex for 10 seconds at maximum speed then the homogenate was centrifuged (3000 rpm) for 10 minutes at 4°C. The supernatant (containing the cytoplasmic fraction) was transferred into a clean micro-centrifuge tube (used for CAIX detection).
The pellet was re-suspended in Cell Extraction Buffer (CEB) [CEB; 10 mM Tris (pH 7.4), 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM NaF, 20 mM Na4P2O7, 2 mM Na3VO4, 1% Triton X-100, 10% glycerol, 0.1% SDS, 0.5% deoxycholate supplemented with 1 mM PMSF (stock is 0.3 M in DMSO)] (BioSource International, Inc., USA) containing protease inhibitors (250μL of protease inhibitor cocktail per 5mL CEB) (Sigma-Aldrich, Germany) for 30 minutes on ice. Subsequently, the mixture centrifuged for 30 minutes at maximum speed at 4°C. The supernatant (nuclear fraction) transferred into a clean microcentrifuge tube (used for immunological assays to detect NF-kB/p65 and p50 subunits).
Protein concentration (for cytoplasmic and nuclear fractions) was determined using Biuret reagent kit (Biodiagnostic Co Ltd; Egypt) according to the manufacturer instructions. Aliquots were kept at -80°C The cervical carcinoma cell line HeLa cells (VACSERA, Egypt) were cultured in complete medium containing DMEM (Dulbecco's Modified Eagle Medium; Lonza, Belguim) supplemented with 10% fetal calf serum (Gibco, UK), 1% antibiotics (streptomycin, penicillin; Gibco, UK), and 1% L-Glutamine (Biowhiyyaker Europe, Belgium). Cells were used as positive control for CAIX after triggering its expression by high cell density and hypoxia imitation by CoCl2. Cells were grown for full confluence in complete medium containing 240 mM CoCl2 (Sigma, USA) (as hypoxia-mimetic agent that artificially induce hypoxia and activate the cell density-dependent CAIX expression via separate but interdependent pathway of PI3K (phosphoinositide 3-kinase) activation and a minimal level of HIF-1; Kaluz et al., 2002) at 37 ºC and 5% CO2 for 24 hours. The medium was then removed and cells were washed twice using 1X PBS (Gibco, UK).
Cells were Trypsinized (Freshney, 2010) and the pellet was subjected to repeated cycles (3 cycles) of freezing (at -80C) and thawing (on ice). Subsequently, the pellet was suspended in 300 ml of CEB and kept on ice for 30 minutes with vortex at 10 minutes intervals. Following incubation, the suspension was centrifuged at 13,000 rpm for 10 minutes and the supernatant (containing the whole protein extract) was collected and protein concentration was detected then kept at -80C till used to assay CAIX.
Detection of CAIX
CAIX initially was detected using dot blot analysis (Galperin et al., 2004; Magi & Liberatori, 2005) to detect the optimum hybridization conditions, then detected by western blot analysis using western blot kit (BioBasic, Inc., Canada) according to the manufacturer instructions. Hybridization was performed using anti-rabbit anti-CAIX (raised against a synthetic peptide corresponding to amino-acids 432-448 of human CAIX; Thermo Fisher Scientific, USA) (1:100) over night at RT with gentle agitation. Unbound antibody washed by 1X PBS (supplemented with 0.05% Tween-20) and the membrane was then incubated with horseradish peroxidase labeled antirabbit antibody (1:2500) (Amersham Biosciences, UK) for 1 hour at RT with gentle agitation. After wash, the membrane was soaked in DAB (3, 3' Diaminobenzidine) substrate solution (BioBasic, Inc., Canada) and agitated for a few minutes till the bands became visible. The color development was stopped by rinsing the membrane by distilled water. The membrane was photographed and signals were scored according to the intensity.
Immunological Assays
NF-κB p65 was detected by sandwich Enzyme Linked-Immuno-Sorbent Assay (ELISA) (BioSource International, Inc., USA) according to the manufacturer instructions. Activated NF-kB/p50 was assessed using a transcription factor assay (Rockland Immunochemicals, Inc., USA); a relatively new test which is a hybrid between ELISA and EMSA (electrophoretic mobility shift assay) where the wells are coated by a specific sequence of dsDNA (double-stranded Deoxyribonucleic acid) recognized by the transcription factor to be assessed, instead of an antibody as in a classical ELISA.
Statistical Analysis
Data analysis performed using Statistical Package for Social Sciences (SPSS) (SPSS Inc., USA) version 11.5. Normality tests showed abnormally distributed continuous variables (K.S < 0.05) except age thus it was described by mean and standard deviation (M ± SD). Abnormally distributed variables were described using the median and range (minimum and maximum) for quantitative variables and by percentage for qualitative ones. Non-parametric statistics were applied to investigate relations between quantitative variables using the Spearman's rank correlation. Differences between groups regarding quantitative variables were done using the Mann Whitney U test if it was between two independent groups while Kruskal Wallis  2 used if it was between more than two groups. Regarding qualitative variables, the difference between groups was performed using the Fishers exact test (in case of 2x2 tables) or the Monte Carlo test (in case of rxc tables) due to invalid X 2 . Associations between qualitative variables were done using the 2 test, and Monte Carlo P was used due to small frequencies. All tests were two-sided and the significance was set at 0.05. The survival curve was constructed using Kaplan-Meier plots and P65 also showed no significant difference with any of tumour grade, lymph node metastasis (LNM), and the status of ER, PR (total) or Her-2/neu or menopausal status (Table 5 ). No correlation was observed with any of age, the number of the involved lymph node (LN), tumour size, the status of ER, PR (total) or Her-2/neu, P50 binding activity, or CAIX expression (Table 6) .
NF-B (p65)
(ng/ml) P value NF-B (p50) Table  4 ). It also differed in proportion of both ER/CAIX positive tumours than ER/CAIX negative tumours (p = 0.059) and CAIX positive than CAIX negative tumours (p = 0.068).
CAIX expression was detected in 84% of tumour specimens (Table 1 & Figure 2 ) whereas; no expression was detected in normal breast tissue specimens. CAIX expression showed a significant inverse correlation with the number of the involved lymph node (r = -0.417, p = 0.020; Table 6 ). CAIX expression differed in proportion with tumour size (p = 0.068). No significant difference was observed with any other prognostic factors (Table 5) . No correlation was detected between CAIX, p65, or p50 (Table 6 ).
Nottingham prognostic index (NPI) revealed that the majority of patients are of poor NIP (Table 7) proper adjuvant therapy after surgery which would account for high disease free survival (DFS) ( Table 1 ). The only one case with good NPI was a triple negative breast cancer case. No statistical difference was observed in the hypoxic markers and the NPI groups (Table 7) . Also absence of significant difference between p65 and LNM was reported apart from the LNM status and sample size. In Hou (2003) and Montagut (2006) studies, the majority of cases were negative for LNM [(52/82; 63.4%), and (28/51; 55%); respectively] while the majority of our cases were positive (23/31; 74.2%). Although no relation was observed between CAIX and LNM status in the current study and others Tan et al., 2009) , an inverse significant correlation was observed between CAIX and the number of the involved lymph nodes reflecting a possible protective role of CAIX in subset of patients with IDC breast cancer. In contrast, in a study containing 253 breast cancer tissue samples, this relation was absent (Span et al., 2003) . This might be due to the detection method (protein versus gene expression), and/or sample size (31 versus 253). Larger cohort study is mandatory to further investigate a possible dual role of CAIX in breast cancer.
Although no relation was observed between elevated level of nuclear p65 or CAIX and tumor grade, a significant relation was observed with p50. The expression of the p50 rate was higher in tumors of higher grade (i.e. with high proliferative potential). This result is consistent with that previously reported by Hou et al., (2003) . Absence of relation with p65 and presence of it with p50 would reflect the dominance of p50 heterodimers (p50)2 in the examined specimens. (P50)2 is known to be able to work as a transcriptional regulator on genes on both repressed and active chromatins and act as transcriptional repressor or activator depending on the cellular protein pools and stimuli (Koong et al., 1994 Singh et al., 2007) have demonstrated that higher levels of NF-kB are associated with ER negative status than in ER-positive in cells and tumours and most predominantly in ER-negative/Her-2/neu-positive breast tumours. However, the P65 nuclear concentration in the present study is numerically higher in ERpositive than ER-negative tumours (53.5 versus 36.7 pg/ml; respectively). Absence of the relation between p65 level and ERstatus in the current study might be due to the fact that most of the breast cancer tumours were ER-positive (23/31; 74%) and the ER-negative/Her-2/neu-positive were 5/31 (16%; with 3/31 with Her-2/neu overexpression). In addition, controversial results would be explained by the fact that the mutually antagonistic cross-talk between the NF-B and ER signalling pathways occurs via various mechanisms which might be stimulus or cell type specific.
The malignant progression of some breast cancers, however, is coincident with a shift from estrogen dependence to estrogen independence and, notably, this shift also coincides with an increase in both NF-B activities (Nakshatri et al., 1997; Pratt et al., 2003) and the expression of some NF-B target genes (Freund et al., 2004) . It has been also shown that Her-2/neu expression leads to down regulation of ER and activation of NF-B (Ahmed et al., 2006) . Thus higher levels of p65 in ER-positive tumours than normal breast specimens (53.5 versus 30.5pg/ml) might indicate a pre-transition state towards loss of ER and acquisition of Her-2/neu overexpression. However, further studies are mandatory to prove this hypothesis.
Interestingly, although no significant difference was observed between the p50 binding activity in tumor and their normal counterparts, a significant inverse relation was observed between ER and p50 subunit in tumor specimens in the present and previous studies (Nakshatri et The expression rate of p50 in ERα-negative tumors (regardless the status of Her-2 in seven of our samples) suggest the activation of p50 which is close to the data obtained by Biswas et al., (2004) and may foreshadow increased therapeutic resistance for these patients, as suggested by Pratt et al., (2003) .
Three cases expressed higher levels of p65 (>100 pg/ml). Two cases out of the three cases ( Lerebours et al., 2008; Ahmed, 2010) reported that the NF-B signature of IBC offers an explanation for the inflammatory symptoms because NF-B is an activator of several inflammatory genes including chemotactic genes, growth factors, angiogenic factors, and matrix metalloproteinase, which are responsible for metastasis, cell proliferation, and angiogenesis, processes known to belong to the biology of IBC.
The limited number of IBC cases in the current study could also explain the absence of significance between [NF-B] and other histopathological parameters. One of the two cases with IBC in our study was ER+, Her-2+, [NF-B = 152 pg/ml] still alive. The other case was ER-, Her-2-, [NF-B = 119 pg/ml] and had history of breast sarcoma which recurred as IDC followed by death within one year of the elective surgery. This might add further possible differential role in metastatic IBC than non metastatic IBC which might be confirmed in the future studies.
Conclusion
Although no relation was observed between p65, p50, and CAIX, binding activity of p50 and CAIX concentration might be used as prognostic markers in IDC. Patients with elevated level of CAIX would benefit from CAIX inhibitors (as adjuvant therapy) and imaging probes (in diagnosis and follow up). Similarly, patients with elevated level of p50 would benefit from natural (such as piperlongumine, alpha tomatine…etc) and synthetic p50 antagonists.
